Latest Asx Listings News

Queste Communications reported a slight net cash outflow from operations in November 2025 but maintains robust liquidity supported by a substantial loan facility and liquid ASX-listed investments.

The Australian Taxation Office has issued a final Class Ruling clarifying the tax treatment of TPG Telecom’s recent $3 billion capital return and special dividend, confirming no part of the capital return is taxable as a dividend.

6K Additive, Inc. launches a fully underwritten A$48 million IPO on the ASX, aiming to scale its innovative scrap-based metal powder production for additive manufacturing. The capital raise supports a major capacity expansion backed by a US Department of Defense grant.

QPM Energy has raised $30.3 million through an oversubscribed share placement and signed a $40 million convertible note term sheet, paving a clear funding path for its 112MW Isaac Power Station project.

QPM Energy Limited has voluntarily suspended its ASX securities pending a significant announcement on a strategic investment and capital raising, expected by December 4, 2025.

Melbana Energy has confirmed that its Executive Chairman, Andrew Purcell, is exempt from re-election under ASX Listing Rule 14.4, following a detailed response to ASX's compliance query.

Atomic Eagle Limited has announced a substantial new Exploration Target at its Muntanga Uranium Project in Zambia, highlighting significant potential resource growth. The company plans a fully funded $20 million drilling campaign in 2026 to expand its uranium resource base.

Orange Minerals NL has raised $3.18 million at a premium, backing an ambitious exploration push in Australia and Ghana. Key cornerstone investments and director commitments highlight strong confidence in the company’s growth strategy.

SolGold plc has unanimously rejected a non-binding acquisition proposal from Jiangxi Copper, triggering a notable share price rally that has significantly enhanced DGR Global’s valuation as a major SolGold shareholder.

Ryder Capital Limited has announced an on-market buy-back program targeting up to 7.56 million ordinary shares, signaling a strategic move in capital management starting December 2025.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Brightstar Resources has completed its acquisition of Aurumin Limited, converting Aurumin shares and options into Brightstar securities and prompting Aurumin’s imminent delisting from the ASX.